60 Degrees Pharmaceuticals, Inc. (SXTP)
1.04
+0.01
(+0.97%)
USD |
NASDAQ |
Aug 31, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Total Long Term Debt (Quarterly) : 0.1512M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1512M |
| March 31, 2026 | 0.152M |
| December 31, 2025 | 0.1528M |
| September 30, 2025 | 0.1538M |
| June 30, 2025 | 0.1543M |
| March 31, 2025 | 0.1553M |
| December 31, 2024 | 0.1559M |
| September 30, 2024 | 0.1567M |
| June 30, 2024 | 0.1575M |
| Date | Value |
|---|---|
| March 31, 2024 | 0.1583M |
| December 31, 2023 | 0.1591M |
| September 30, 2023 | 0.1614M |
| June 30, 2023 | 25.34M |
| March 31, 2023 | 23.18M |
| September 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 18.76M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Harrow, Inc. | 299.80M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |
| Johnson & Johnson | 37.34B |